Literature DB >> 29430621

Ageing-related aorta remodelling and calcification occur earlier and progress more severely in rats with spontaneous hypertension.

Xiaoyun Shi1, Yajing Bai2, Yilang Ke1, Ruiqi Chen1, Xiaohong Lin3, Lianglong Chen4, Huashan Hong5.   

Abstract

The effects of hypertension on vascular remodelling, ageing and calcification are not fully understood. In this study, we monitored the dynamic changes of aorta remodelling, senescence and calcification in spontaneously hypertensive rats (SHRs) during ageing.
RESULTS: Vascular remodelling and senescence cells occurred in SHR aortas at 24 weeks. The calcium content and calcium deposition of the aorta increased in SHRs at 48 weeks. All of these changes became increasingly significant with ageing. In contrast, these pathologic changes appeared in Wistar-Kyoto (WKY) normotensive rats at a much later stage (72 weeks). These data showed that the ageing-related aorta remodelling, senescence and calcification in SHRs occurred earlier and progressed more severely than in WKY rats.
CONCLUSION: Ageing-related vascular remodelling and calcification were accelerated and augmented in SHR aortas.

Entities:  

Mesh:

Year:  2018        PMID: 29430621     DOI: 10.14670/HH-11-971

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  2 in total

Review 1.  Animal Models of Hypertension: A Scientific Statement From the American Heart Association.

Authors:  Lilach O Lerman; Theodore W Kurtz; Rhian M Touyz; David H Ellison; Alejandro R Chade; Steven D Crowley; David L Mattson; John J Mullins; Jeffrey Osborn; Alfonso Eirin; Jane F Reckelhoff; Costantino Iadecola; Thomas M Coffman
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

2.  Predictors of coronary artery calcification and its association with cardiovascular events in patients with chronic kidney disease.

Authors:  Xue-Rong Wang; Liang- Yuan; Rui- Shi; Huan- Li; De-Guang Wang; Yong-Gui Wu
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.